BTIG Reiterates Buy on Boston Scientific, Maintains $64 Price Target
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Marie Thibault has reiterated a Buy rating on Boston Scientific (NYSE:BSX) and maintained a price target of $64.
December 29, 2023 | 12:43 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BTIG analyst Marie Thibault reiterates a Buy rating on Boston Scientific with a maintained price target of $64.
The reiteration of a Buy rating by a BTIG analyst, along with the maintenance of a $64 price target, is a positive endorsement for Boston Scientific. This could lead to increased investor confidence and a potential short-term uplift in the stock price, as it signals analyst belief in the company's value and future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100